Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
A large bearish position on Moderna (NASDAQ:MRNA) has been noticed, with 15 uncommon options trades spotted. The sentiment of these big-money traders is split between 46% bullish and 53% bearish. Whales have been targeting a price range from $100.0 to $165.0 for Moderna over the last 3 months. UBS upgraded its action to Buy with a price target of $191, while Morgan Stanley maintained their Equal-Weight rating with a price target of $128.
July 12, 2023 | 5:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A large bearish position has been taken on Moderna, with a split sentiment among big-money traders. Analysts have mixed views, with UBS upgrading to Buy and a price target of $191, while Morgan Stanley maintains an Equal-Weight rating with a price target of $128.
The large bearish position taken on Moderna indicates that some investors expect the stock price to decrease. This, combined with the split sentiment among big-money traders, suggests uncertainty around the stock's performance. However, the upgrades from UBS could potentially offset some of this bearish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100